Clinical Trial Update: Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP) [Phase 3]

View source ↗

Summary

Phase 3 trial of apatinib after systemic therapy in hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2024-01-22